AUTHOR=Wang Linjie , Wang Xiaojing , Gong Fengying , Pan Hui , Zhu Huijuan 

TITLE=Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy

JOURNAL=Frontiers in Endocrinology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1285477

DOI=10.3389/fendo.2023.1285477

ISSN=1664-2392

ABSTRACT=<sec><title>Objective</title><p>To summarize the clinical characteristics of 4 male prolactinoma patients with severe obesity.</p></sec><sec><title>Methods</title><p>The clinical data of all the patients were retrospectively analyzed.</p></sec><sec><title>Results</title><p>All the patients visited our hospital for severe obesity at the age of 16-30 years old with their body mass index (BMI) of 37.9-55.9 kg/m<sup>2</sup>. All the patients were obese since childhood, even at birth. Hyperprolactinemia (72.3-273.0 ng/ml) was found during the etiological screening of obesity and MRI revealed pituitary adenomas. Additionally, all of them had multiple obesity related complications, such as hyperinsulinemia and dyslipidemia. Treatment of dopamine agonists (DAs) effectively normalized their prolactin level and the pituitary MRI reexamination after 6 months of DAs treatment showed the shrinkage of the pituitary adenomas in 3 patients. Their weight also decreased in different degrees (2.70~19.03% lower than the baseline) with improved metabolic profiles.</p></sec><sec><title>Conclusion</title><p>Serum prolactin level should be screened in obese patients, especially those with severe obesity.</p></sec>